Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis

Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis

Joseph R LuttDivision of Arthritis and Rheumatic Diseases, Oregon Health and Science University, Portland, Oregon, USAAbstract: The management of rheumatoid arthritis (RA) has undergone an impressive transformation over the past few decades. Further understanding of the pathophysiology of the diseas...

Full description

Bibliographic Details
Main Author:	Joseph R Lutt
Format:	Article
Language:	English
Published:	Dove Medical Press 2009-05-01
Series:	Open Access Rheumatology : Research and Reviews
Online Access:	http://www.dovepress.com/efficacy-safety-and-tolerability-of-abatacept-in-the-management-of-rhe-a3115

Similar Items

Efficacy, safety and tolerability of using abatacept for the treatment of rheumatoid arthritis
by: Rafael Venson, et al.
Published: (2012-12-01)

Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
by: Augustine JM, et al.
Published: (2012-02-01)

Effectiveness and Safety of Abatacept in Moderate to Severe Rheumatoid Arthritis
by: Lucía Cortejoso-Fernández, et al.
Published: (2011-12-01)

COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF ABATACEPT IN PATIENTS WITH DIFFERENT DURATION OF RHEUMATOID ARTHRITIS
by: M. A. Borisova, et al.
Published: (2017-01-01)

Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis
by: Yannick Degboé, et al.
Published: (2020-06-01)

Abatacept and cardiovascular risk in rheumatoid arthritis: update
by: T. V. Popkova
Published: (2018-01-01)

Experience with abatacept used in the treatment of patients with rheumatoid arthritis
by: V I Mazurov, et al.
Published: (2011-12-01)

Efficacy of Abatacept for Arthritis in Patients with an Overlap Syndrome between Rheumatoid Arthritis and Systemic Lupus Erythematosus
by: Kei Ikeda, et al.
Published: (2013-01-01)

EXPERIENCE OF TREATMENT WITH ABATACEPT IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS
by: Ye. I. Alekseyeva, et al.
Published: (2011-01-01)

Cost-utility analysis of abatacept in rheumatoid arthritis in Italy
by: Simona de Portu, et al.
Published: (2008-03-01)

Immunoprofiling for Prediction of Response to Abatacept in Rheumatoid Arthritis Patients
by: Prodromos Sidiropoulos, et al.
Published: (2016-01-01)

EXPERIENCE OF TREATMENT WITH ABATACEPT IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS
by: Ye. I. Alekseyeva, et al.
Published: (2011-01-01)

EXPERIENCE WITH ABATACEPT IN THE THERAPY OF RHEUMATOID ARTHRITIS IN THE REPUBLIC OF TATARSTAN
by: С А Лапшина, et al.
Published: (2012-12-01)

THE EFFECT OF ABATACEPT ON BLOOD BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: M. A. Borisova, et al.
Published: (2017-09-01)

Comparative clinical utility of once-weekly subcutaneous abatacept in the management of rheumatoid arthritis
by: Rakieh C, et al.
Published: (2014-04-01)

Subcutaneous abatacept in rheumatoid arthritis: A real-life experience
by: Juan Camilo Sarmiento-Monroy, et al.
Published: (2019-12-01)

Majocchi’s granuloma developing in the setting of abatacept use for rheumatoid arthritis
by: Natalie Villa, et al.
Published: (2020-06-01)

Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis
by: Waka Yokoyama-Kokuryo, et al.
Published: (2020-03-01)

Safety and efficacy of abatacept among patients with refractory rheumatoid arthritis: Experience from a North Indian Tertiary Care Hospital
by: M N Arjun, et al.
Published: (2018-01-01)

Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain
by: R. Ariza, et al.
Published: (2014-07-01)

Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network
by: Jean-Hugues Salmon, et al.
Published: (2020-05-01)

Multicenter, observational clinical study of abatacept in Japanese patients with rheumatoid arthritis
by: Noriyoshi Ogawa, et al.
Published: (2019-01-01)

Pneumocystis jirovecii Pneumonia in a Patient with Rheumatoid Arthritis Treated with Abatacept
by: Fabio E. Ospina, et al.
Published: (2014-01-01)

Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study
by: Giulia Cassone, et al.
Published: (2020-01-01)

Efficacy of abatacept in juvenile idiopathic arthritis related uveitis
by: Nikishina IP, et al.
Published: (2011-09-01)

Common Transcriptomic Effects of Abatacept and Other DMARDs on Rheumatoid Arthritis Synovial Tissue
by: Clement Triaille, et al.
Published: (2021-08-01)

EXPERIENCE OF TREATMENT WITH ABATACEPT IN CHILD WITH JUVENILE RHEUMATOID ARTHRITIS AND SECONDARY INEFFICIENCY OF INFLIXIMAB
by: I.P. Nikishina, et al.
Published: (2011-05-01)

EXPERIENCE OF TREATMENT WITH ABATACEPT IN CHILD WITH JUVENILE RHEUMATOID ARTHRITIS AND SECONDARY INEFFICIENCY OF INFLIXIMAB
by: I.P. Nikishina, et al.
Published: (2011-01-01)

Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis
by: Mathieu S, et al.
Published: (2013-12-01)

ABATACEPT FOR RHEUMATOID ARTHRITIS: A NOVEL FORMULATION, NEW MECHANISMS, NEW POSSIBILITIES
by: E. L. Nasonov
Published: (2015-10-01)

Gene expression regulated by abatacept associated with methotrexate and correlation with disease activity in rheumatoid arthritis.
by: Céline Derambure, et al.
Published: (2020-01-01)

Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis
by: Benucci M, et al.
Published: (2018-06-01)

A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations
by: Wells AF, et al.
Published: (2014-02-01)

Efficacy and tolerability of abatacept treatment: results of 12 months observation
by: M A Borisova, et al.
Published: (2018-05-01)

EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH ABATACEPT AND METHOTREXATE AND MONOTHERAPY WITH METHOTREXATE IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: V. A. Kel'tsev, et al.
Published: (2012-11-01)

Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study
by: Ernest Choy, et al.
Published: (2021-02-01)

Cost per responder for upadacitinib vs abatacept in patients with moderate-to-severe Rheumatoid Arthritis in Italy
by: Roberto Caporali, et al.
Published: (2021-07-01)

Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: cumulative clinical trial data
by: Teresa A. Simon, et al.
Published: (2021-01-01)

Analysis of Mitogen-Activated Protein Kinases in Bone and Cartilage of Patients with Rheumatoid Arthritis Treated with Abatacept
by: Katsuaki Kanbe, et al.
Published: (2016-04-01)

Analysis of Mitogen-Activated Protein Kinases in Bone and Cartilage of Patients with Rheumatoid Arthritis Treated with Abatacept
by: Katsuaki Kanbe, et al.
Published: (2016-01-01)

Cannot write session to /tmp/vufind_sessions/sess_neht50daah6jqioc7rhc74a6db